Home > M&A deals 2020 > Boehringer Ingelheim GmbH acquires Labor Dr. Merk & Kollegen GmbH
Add-on Acquistion · Life Science · December 2020

Boehringer Ingelheim GmbH acquires Labor Dr. Merk & Kollegen GmbH

On December 9, 2020, Boehringer Ingelheim GmbH acquired Labor Dr. Merk & Kollegen GmbH, a life science company in Germany.

Deal at a glance

AnnouncedDecember 9, 2020 TypeAdd-on Acquistion TargetLabor Dr. Merk & Kollegen GmbH Buyer Boehringer Ingelheim GmbH SectorLife Science LocationGermany ValueNot disclosed

Target company

Labor Dr. Merk & Kollegen GmbH
Germany
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Boehringer Ingelheim GmbH
Company · 8 deals on record
  • 2nd transaction in life science
  • 1st transaction in Germany
8deals, all time
4in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Tubulis GmbHSame sector and country · Apr 2026
STADA Arzneimittel AGSame sector and country · Mar 2026
Tubulis GmbHSame sector and country · Mar 2024

Questions about this deal

Who acquired Labor Dr. Merk & Kollegen GmbH?Boehringer Ingelheim GmbH acquired Labor Dr. Merk & Kollegen GmbH on December 9, 2020.

What type of deal was it?It was a add-on acquistion in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).